Announced Wed, 6 May · 18:24 IST

Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

TATVA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹1317.50
prior close
₹1332.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.7+0.2-0.5+2.8+1.6-2.8-3.8-4.4-5.1-14.5-13.1-5.9
Up moveDown movePending
AI summary

Tatva Chintan Pharma Chem Limited has disclosed the schedule for its Q4 FY26 and full year FY26 earnings call, to be held on Saturday, 16 May 2026 at 5:00 PM IST. The call will be hosted by ICICI Securities and will feature Managing Director Mr. Chintan Shah and CFO Mr. Ajesh Pillai. This is a routine regulatory intimation under SEBI LODR Regulation 30, informing stakeholders about the company's post-results analyst call. The details will also be uploaded on the company's website. The earnings call follows the announcement of financial results for the quarter and year ended 31 March 2026.

Likely market impact

No material impact on the stock — this is a standard procedural disclosure informing investors and analysts about an upcoming earnings call where they can hear management discuss Q4 and FY26 results.